Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
Good Assays for Bad Immunogenicity
Avoid “Bad” Immunogenicity by Using Assays That Are More Sensitive and Can Adapt to Increasingly Complex and Specialized Drugs
For full access to this article login to GEN Select now.
Fledgling Firms Needed to Fill U.K. Void
Industry Success Requires that New Businesses Be Started to Replace Those Bought by Pharma
- England’s Greater South East (an area including both Brighton and London) is the biggest health technology cluster in the world, according to David Parry, Ph.D., CEO of the South East Health Technologies Alliance. It is home to 4,700 biotech, diagnostic, medical device, and pharma companies, generating £100 billion ($142.6 ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.